×

Sign In

Astrazeneca’s breast cancer drug fails late-stage trial

By Thomson Reuters Sep 11, 2026 | 4:33 PM

Sept 11 (Reuters) – AstraZeneca ‌said on Friday ‌its breast ⁠cancer ⁠drug failed to ⁠meet ⁠the main goal of improving ‌progression-free survival ⁠during a late-stage ⁠trial.

(Reporting ‌by ⁠Christy Santhosh ‌in Bengaluru; ⁠Editing by Tasim Zahid)

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.

Three vehicles collide in northern Russia, 12 dead

Contractor said Reflecting Pool damage stemmed from repairs, NYT reports

Train derails in northern France, injuring around 20 people

'It's all coming back to me now': Celine Dion returns to the stage in Paris

Astrazeneca's breast cancer drug fails late-stage trial

North Korea launches unidentified projectile toward East Sea, Yonhap reports